Related by context. All words. (Click for frequent words.) 74 BrachySil TM 71 successfully commercialize Iluvien 71 Azedra 70 CBLC# 70 OvaRex ® MAb 70 Proxinium TM 70 Panzem R NCD 70 TBC# 69 IMA# 69 Exelixis compounds 69 PrevOnco ™ 69 Allovectin 7 69 TRISENOX ® 69 GRNVAC1 69 SIR Spheres 69 Archexin 69 OvaRex R 69 Phase #b/#a clinical 68 farletuzumab 68 SinuNase TM 68 MAGE A3 ASCI 68 mertansine 68 pain palliation 68 Gliadel Wafer 68 OncoVEX GM CSF 68 Cloretazine ® 68 EOquin TM 68 AEG# 68 Phase 1b clinical trials 68 BrachySil ™ 68 Phase IIa trials 68 Pemetrexed 68 Alocrest 68 CCX# 68 OncoVEX 68 Urocidin 68 drug GAP #B# 68 liposomal formulation 68 targeted radiotherapeutic 68 Phase IIb clinical trials 68 Vicinium TM 68 SEPET TM 68 Xanafide 67 riociguat 67 Annamycin 67 Tarceva TM 67 CYT# potent vascular disrupting 67 oral prodrug 67 Fodosine 67 investigational monoclonal antibody 67 GLP toxicology studies 67 PSMA ADC 67 VNP#M 67 Telatinib 67 PrevOnco 67 IRX 2 67 amrubicin 67 HuMax CD4 67 CTAP# Capsules 67 acetonide FA 67 phase IIb clinical 67 PEGylated interferon 67 HuMax EGFr 67 efaproxiral 67 ruxolitinib 67 preclinical efficacy 67 NP2 Enkephalin 67 Anthim 67 MGN# 67 oral taxane 67 midstage trials 67 Onconase 66 Myocet 66 QuadraSphere 66 LymphoStat B TM 66 candidate TNFerade biologic 66 MYDICAR ® 66 Neuradiab 66 rxRNA 66 Phase Ib clinical trials 66 radiotherapeutic 66 oral rivaroxaban 66 Amrubicin 66 LEP ETU 66 Tectin TM 66 DCVax R 66 Cethrin R 66 Daclizumab 66 Panzem R 66 KNS # 66 CEQ# 66 Davanat 66 GALNS 66 Zybrestat 66 Afatinib 66 G#DT 66 ularitide 66 Civacir 66 TOCOSOL Camptothecin 66 cannabinor 66 oral ridaforolimus 66 REOLYSIN ® 66 StemEx R 66 immunotherapeutic agent 66 alvespimycin 66 Teysuno 66 docetaxel Taxotere ® 66 EFAPROXYN 66 Glufosfamide 66 Onalta ™ 66 metaglidasen 66 favorable pharmacokinetic profile 66 budesonide foam 66 galiximab 66 VersaFilm 66 Aurexis 66 generation purine nucleoside 66 Sym# 66 NP2 66 vinorelbine tartrate 66 Microspheres 66 OHR/AVR# 66 immunotherapeutic vaccine 66 including eniluracil ADH 66 pharmacokinetic PK study 66 Elagolix 66 PROMUS Element Stent 66 carcinoma HCC 66 docetaxel Taxotere R 65 corticosteroid dexamethasone 65 EOquin 65 MyVax R 65 BEMA TM Fentanyl 65 Phase 2b clinical trials 65 ixabepilone 65 reslizumab 65 MGd 65 phase IIb III 65 PNP inhibitor 65 Darinaparsin 65 novel VDA molecule 65 VALSTAR 65 Allovectin 7 ® 65 MOZOBIL 65 phase IIa clinical 65 ABRAXANE ® 65 radiation sensitizer 65 ATL# [001] 65 TPI ASM8 65 Phase #b/#a 65 Dacogen injection 65 refractory chronic lymphocytic 65 VitiGam 65 Exherin TM 65 Glassia 65 liposomal doxorubicin 65 mapatumumab 65 ganetespib 65 anticancer compound 65 ILUVIEN ® 65 Vidaza azacitidine 65 AzaSite Plus 65 HepaSphere 65 ELACYT 65 Cloretazine 65 TAXUS Element Paclitaxel Eluting 65 OMS#HP 65 oxymorphone ER 65 Safinamide 65 RSR# 65 YONDELIS 65 Azedra TM 65 Onalta 65 lomitapide 65 Soliris eculizumab 65 AAV vectors 65 Ceflatonin 65 MyVax 65 Actimmune ® 65 LEUKINE 65 GVAX ® 65 rPA anthrax vaccine 65 Phase Ib study 65 PI3K/Akt pathway inhibitor 65 NeuVax 65 docetaxel Taxotere 65 Aflibercept 65 ara C 65 histamine dihydrochloride 65 HQK 65 acyclovir Lauriad R 65 dose cohort 65 OMP #M# 65 Degarelix 65 pharmacodynamic properties 65 CVac 65 Dalbavancin 65 RhuDex ® 65 Lovaxin C 64 UPLYSO 64 #I TM# 64 LymphoStat B belimumab 64 Saforis 64 Spiegelmer ® 64 NB S# strontium malonate 64 bardoxolone 64 hormone LHRH antagonist 64 Insegia 64 Iluvien TM 64 Traficet EN 64 Nanobody 64 Liposomal 64 Ixempra 64 TELCYTA 64 tanespimycin 64 CoFactor 64 volociximab 64 afamelanotide 64 AAG geldanamycin analog 64 Iluvien ® 64 Survivin antagonist 64 DXL# 64 Pertuzumab 64 BNC# 64 Onrigin 64 ocular formulation 64 CINTREDEKIN BESUDOTOX 64 Vandetanib 64 Ferumoxytol 64 Solazed 64 neratinib 64 FOLOTYN ® 64 phase IIb trial 64 GV# [001] 64 GAMMAGARD 64 SNT MC# 64 CRMD# 64 midstage clinical trials 64 PHX# 64 Epanova 64 leading oral taxane 64 Litx 64 trastuzumab DM1 T DM1 64 paclitaxel poliglumex 64 TLK# 64 drug eluting stent DES 64 PROCHYMAL 64 Kamada AAT 64 forodesine 64 TH# [003] 64 Angiocept 64 ZK EPO 64 TYSABRI natalizumab 64 CINQUIL 64 cediranib 64 Novolimus 64 recurrent metastatic 64 arsenic trioxide ATO 64 TAFA# 64 oral picoplatin 64 delivers fluocinolone acetonide FA 64 Aviptadil 64 Amplimexon 64 personalized immunotherapy 64 orBec 64 compound KOS 64 ospemifene 64 ZEVALIN ® 64 elotuzumab 64 Dyloject TM 64 BRIM2 64 proteasome inhibitor 64 Polymer Microspheres 64 sipuleucel T 64 tolevamer 64 DEEP AF 64 Glypromate 64 ALK inhibitors 64 DC Bead 64 rhThrombin 64 DEB# 64 PANVAC VF 64 WX UK1 64 Cloretazine R VNP#M 64 IL# PE#QQR 64 Troxatyl 64 therapeutic monoclonal antibody 64 KIACTA ™ 64 doxorubicin Transdrug ® 64 TELINTRA 64 Genasense ® oblimersen 64 BiovaxID TM 64 Targretin capsules 64 Irinotecan 64 RSD# oral 64 Mipomersen 63 Tamibarotene 63 AKT inhibitor 63 concurrent chemoradiation 63 MYDICAR 63 nalbuphine ER 63 cancer immunotherapies 63 oral deforolimus 63 regorafenib 63 Cerashield 63 Thrombin 63 DAVANAT 63 lintuzumab SGN 63 metastatic colorectal 63 isavuconazole 63 teriflunomide 63 irinotecan hydrochloride 63 romidepsin 63 Phase Ib clinical 63 OncoVex 63 Voraxaze 63 trastuzumab DM1 63 oral anticancer 63 DermaVir Patch 63 IND submission 63 Ophena TM 63 Intarcia 63 R#/MEM # 63 Acute Radiation Syndrome ARS 63 ASONEP 63 phase IIb study 63 assessing T DM1 63 Dual Opioid 63 Bayer HealthCare Onyx Pharmaceuticals 63 elacytarabine 63 TLR9 agonist 63 Soliris TM eculizumab 63 EndoTAG 63 phase Ib 63 Xelox 63 Phase Ib II 63 omega interferon 63 BioSilicon TM 63 NeuroSTAT ® 63 anti angiogenic agent 63 PF # [002] 63 OMNARIS Nasal Spray 63 TOCOSOL Paclitaxel 63 fluoropyrimidine 63 Chemophase 63 Tarmogen 63 PREOS 63 Temsirolimus 63 CD# monoclonal antibody 63 micafungin 63 Targeted Chemotherapy 63 GAP #B# 63 thymalfasin 63 topical diclofenac 63 Navelbine ® 63 hoFH 63 Cellegesic 63 IV Busulfex 63 BLA filing 63 BENLYSTA ® 63 Frova ® 63 Hycamtin 63 Curaxin CBLC# 63 LHRH antagonist 63 Orazol 63 Seliciclib 63 Hepatocellular Carcinoma HCC 63 RezularTM 63 BAL# [002] 63 T Pred 63 microsphere therapy 63 indibulin 63 trastuzumab Herceptin 63 phase 2a 63 Dabigatran etexilate 63 drug ISA# 63 etanercept Enbrel 63 OncoGel 63 catheter occlusion 63 Dacogen decitabine 63 vapreotide acetate 63 ATPace TM 63 erlotinib Tarceva ® 63 Phase III randomized controlled 63 recurrent metastatic ovarian cancer 63 IAP inhibitor 63 UVIDEM 63 histone deacetylase inhibitor 63 Neuvenge 63 thalidomide Thalomid 63 ChronVac C R 63 ISTODAX 63 MEK inhibitors 63 CTA# Injection 63 seliciclib CYC# 63 Aplidin 63 cetrorelix pamoate 63 PSN# [001] 63 Oral NKTR 63 tramiprosate Alzhemed TM 63 Zelrix 63 lucinactant 63 Pirfenidone 63 aerosolized KL4 surfactant 63 Personalized Immunotherapy 63 GVAX 63 MEK inhibitor RDEA# 63 NEUMUNE 63 sodium thiosulfate STS 63 PDX pralatrexate 63 dermal patch 63 S1P antibody 63 LungAlert TM 63 PROSTVAC TM 63 antibody MAb 63 incyclinide 63 Apaziquone 63 Onco TCS 63 liposomal amphotericin B 63 Virulizin ® 63 MoxDuo ® 63 NexACT 63 phase IIb 63 Radezolid 63 adjuvant colon cancer 63 oral gallium 63 AZILECT ® 63 Heplisav 63 Phase IIIb clinical 63 Bezielle 63 Resten NG 63 PhG alpha 1 63 tezampanel 63 ZACTIMA 63 Alfimeprase 63 ChronVac C ® 63 candidate deforolimus 63 GRN# 63 Pennsaid R 63 multicenter Phase II 63 refractory prostate cancer 63 depsipeptide 63 talactoferrin 63 Zingo TM 63 Zemiva TM 63 Progenta TM 63 Toraymyxin TM 63 receptor tyrosine kinase inhibitor 63 BioSilicon 63 Epratuzumab 63 RECOTHROM R 63 chemotherapy cisplatin 63 Cloretazine VNP#M 63 Phase #/#a 63 Zemplar Capsules 63 sorafenib Nexavar 63 octreotide implant 63 Enkephalin 63 CIMZIA TM 63 Tykerb lapatinib 63 ACAPODENE 63 Ozarelix 63 Icatibant 63 MET amplification 63 octreotide acetate 63 torezolid phosphate 63 Solazed TM 63 edifoligide E2F Decoy 63 Asentar 63 Avastin bevacizumab 63 Augment TM 63 Bicifadine 63 ClearPath HDR 63 acyclovir Lauriad ® 63 CIMZIA ™ 63 phase Ib clinical 63 nanopharmaceutical 63 rALLy clinical trial 63 #D#C# 63 monoclonal antibody conjugated 63 Zarnestra 63 Epirubicin 63 nasal calcitonin product 63 BLA submission 63 tolerability pharmacokinetics 63 fluocinolone acetonide 63 Generx ™ 63 Etoposide 63 SILENOR 63 herpetic keratitis 63 Mitoxantrone 63 Corlux 63 urocortin 2 63 liver resection surgeries 63 antiangiogenic agents 63 vidofludimus 63 PolyActive ® 63 hPTH #-# 63 TroVax ® 63 PROVENGE sipuleucel T 63 Arikace 63 aerosolized AAT 63 multidose 62 Golimumab 62 Proellex TM 62 malignant ascites 62 FavId 62 dalbavancin 62 virus HCV protease inhibitor 62 Emezine 62 Loramyc R 62 MKC# MKC# PP 62 eSVS MESH 62 Fludara ® 62 oral salmon calcitonin 62 ReN# 62 metastatic hormone refractory 62 ATL/TV# 62 molecular imaging radiopharmaceutical 62 lapatinib Tykerb 62 Evoltra ® 62 lumiliximab 62 CR# vcMMAE 62 bevacizumab Avastin ® 62 alglucosidase alfa 62 Panzem 62 Hsp# Inhibitor 62 Raptiva ® 62 AdhTAP 62 vosaroxin 62 Zoraxel 62 REPEL CV 62 Erbitux cetuximab 62 TRO# 62 QNEXA ® 62 obatoclax 62 immatics 62 Intravitreal 62 Nexavar sorafenib 62 Specifid 62 AeroLEF TM 62 NuroPro ® 62 XmAb# 62 Varespladib 62 synthetic retinoid 62 Embosphere Microspheres 62 sumatriptan DosePro 62 Pyridorin 62 Phase 1a clinical 62 Xcellerated T Cells 62 Phase #b/#a trial 62 RhuDex TM 62 Muraglitazar 62 INT# [002] 62 HspE7 62 ATPace 62 omacetaxine mepesuccinate 62 Anturol TM 62 radiolabeled TM# 62 PRT# 62 Ereska 62 NEXTERONE 62 BEMA Granisetron 62 Quinamed 62 oncolytic virus therapies 62 hypoxia activated prodrug 62 oral antiviral 62 arsenic trioxide injection 62 biodegradable implant 62 Intravail R 62 tiapamil 62 fibrin sealant 62 CXA 62 Liprostin 62 ProSavin 62 TG# [003] 62 BRAF inhibitor 62 EGFR HER2 62 orally bioavailable 62 Deforolimus 62 HGS ETR1 mapatumumab 62 Cleviprex TM clevidipine 62 PDE4 inhibitor 62 tumor xenograft models 62 imexon 62 vemurafenib 62 Cetuximab Erbitux 62 XL# anticancer compounds 62 Cefazolin 62 Phase IIa trial 62 Ceflatonin ® 62 Fibrin Pad 62 Alequel ™ 62 Urocidin TM 62 OMNARIS HFA 62 JAK inhibitor 62 LEVADEX ™ 62 MyVax personalized immunotherapy 62 Initiate Clinical Trial 62 BEXXAR 62 orally administered inhibitor 62 TNFerade TM 62 dose escalation Phase 62 opioid induced bowel dysfunction 62 brivaracetam 62 Vascular Wrap TM 62 Gleevec imatinib mesylate 62 mocetinostat MGCD# 62 Aerosurf 62 lintuzumab 62 Dendreon Provenge 62 EDEMA3 trial 62 EPODURE 62 TRC# 62 Ketotransdel 62 intravenous acetaminophen 62 TRANSDUR Bupivacaine 62 buccal spray 62 DPX Survivac 62 gemcitabine Gemzar ® 62 cytotoxic therapy 62 Aclidinium 62 dermaPACE TM 62 autologous cellular immunotherapy 62 Pafuramidine 62 pertuzumab 62 Aryplase 62 lenalidomide Revlimid R 62 Vernakalant 62 ONCONASE R 62 dextofisopam 62 CRLX# 62 Urokinase 62 topically applied SEPA 62 rALLy trial 62 GEM OS2 62 Fortical R 62 Eluting Coronary Stent System 62 drug eluting coronary stent 62 prostone 62 Cervista HPV HR 62 Taxotere chemotherapy 62 hereditary deficiency 62 Votrient 62 AGHD 62 Exelon Patch 62 VitiGam TM 62 Cannabinor 62 Vectibix panitumumab 62 oral proteasome inhibitor 62 Neo Urinary Conduit 62 MVA BN R 62 sd rxRNA 62 MKC# 62 Anavex #-# 62 intravesical instillation 62 calcineurin inhibitors 62 Trastuzumab DM1 62 DCVax ® Brain 62 PGL# 62 Zolinza 62 IMPDH inhibitor 62 ARIKACE 62 Combidex 62 EXPAREL ™ 62 ADVANCE PD 62 dirucotide 62 OvaRex 62 Proquin XR 62 metastatic CRC 62 PRTX 62 Biliary System 62 QT QTc 62 either acutely decompensated 62 Omigard 62 novel histone deacetylase 62 Alvesco R 62 Factor VIIa 62 Pivotal Phase III 62 Sestamibi 62 Tesetaxel 62 Perifosine 62 Cloretazine R 62 Velcade bortezomib 62 vivo preclinical 62 NexACT ® 62 Tocosol Paclitaxel 62 huC# DM4 62 enzastaurin 62 VEGF inhibitor 62 Deferiprone 62 DCVax R Brain 62 5 HT3 antagonist 62 CDP# 62 Neovastat 62 aleglitazar 62 rhIGF-I/rhIGFBP-3 62 Synavive 62 Combo Stent 62 AIR# [001] 62 inhaled AAT 62 demonstrated antitumor activity 62 TOCOSOL 62 Nexavar ® 62 systemic anaplastic large 62 DermaPrep 62 maximally tolerated dose 62 Zemiva ™ 62 Tezampanel 62 Abiraterone 62 SPL# Gel vaginal microbicide 62 Qutenza TM 62 hylan GF 62 CIP Fenofibrate 62 DispersinB R 62 Removab 62 Lilly Gemzar 62 ENMD # 62 histone deacetylase HDAC inhibitor 62 DOS# 62 SinuNase ™ 62 Pralatrexate 62 Intravitreal injections 62 Anidulafungin 62 CA9 SCAN 62 LibiGel Phase III 62 EGS# 62 iobenguane 62 Psoraxine R 62 intranasal formulation 62 anti EGFR antibody 62 EDEMA3 62 anti CD# antibodies 62 multicenter Phase III 62 Tesmilifene 62 Argatroban 62 VALSTAR TM 62 ORTHOVISC mini 62 Nebido 62 Oracea TM 61 EndoTAG TM -1 61 PS# [001] 61 XP# XP# 61 kidney urologic 61 StemEx 61 Trabectedin 61 Ozurdex 61 MEK inhibitor 61 GLP1 agonist 61 Provecta 61 antisense drug 61 HGS# 61 Pfizer Sutent 61 gemcitabine chemotherapy 61 Valortim 61 DCVax ® 61 induced macular edema 61 preclinically 61 pan HDAC inhibitor 61 doxorubicin Transdrug R 61 DepoDur 61 Spiegelmer 61 Phase #/#a trial 61 GVAX R 61 Telcyta 61 TLR agonists 61 oral talactoferrin 61 XYNTHA 61 ACUROX ® 61 tremelimumab 61 EVIZON 61 SNALP technology 61 HuMax 61 triphendiol 61 Phase IIb III 61 Microcutter 61 Altera Nebulizer System 61 selective immunoproteasome inhibitor 61 sNDA submission 61 trabectedin 61 Allovectin 7 r 61 Camptosar ® 61 Iressa gefitinib 61 Capesaris 61 Phase IIB 61 Octreotide 61 registrational trial 61 candidate XP# 61 oxybutynin gel 61 Tyrima 61 GED aPC 61 overactive bladder AA# 61 Troxatyl TM 61 Abbokinase 61 myelofibrosis polycythemia vera 61 BioNeutral antimicrobial formulations 61 ALGRX 61 Celgene Revlimid 61 Sutent sunitinib 61 Plenaxis TM 61 Retacrit 61 L BLP# 61 AVE# 61 rNAPc2 61 MAA submission 61 IoGen 61 Prodarsan R 61 AMPK activators 61 pharmacokinetic equivalence 61 relapsed MM 61 SURFAXIN 61 Tanespimycin 61 bovine thrombin 61 Androxal TM 61 Vascugel ® 61 Antigenics QS 61 Tarvacin TM 61 liposomal 61 platforms GVAX 61 efficacy endpoint 61 MKC# MT 61 Sudhir Agrawal D.Phil 61 vascular disrupting agent 61 TACI Ig 61 Achieves Primary Endpoint 61 TRV# [001] 61 dasatinib Sprycel ® 61 Protexia R 61 Multimeric 61 Nanobody ® 61 PrandiMet TM 61 Arsenic trioxide 61 fusion enhancers 61 HCV protease inhibitors 61 EpiCeram 61 Zysolin TM 61 European Sepsis Trial 61 Cotara R 61 relapsed refractory multiple myeloma 61 product platforms AZX# 61 apaziquone 61 Excellarate 61 Marqibo TM 61 ALN TTR# 61 eprotirome 61 Evoltra 61 cilengitide 61 Peginterferon alfa 2b 61 cysteamine bitartrate 61 fallopian tube cancers 61 PARP inhibitor 61 XL# XL# XL# XL# 61 2DG 61 Ophena 61 systemically administered 61 alefacept 61 Besivance 61 HGS ETR1 61 TRISENOX 61 goserelin 61 Hedgehog Pathway Inhibitor 61 Eribulin 61 pharmacodynamic profiles 61 Exherin 61 stent DES 61 paclitaxel Taxol 61 RIGScan CR 61 Kynapid 61 Alpharadin 61 mesylate 61 Vitaxin 61 ThermoDox ® 61 Radiation Therapy SIRT 61 subcutaneous formulation 61 APEX PD 61 Anti Bacterial Envelope 61 chemotherapeutic regimen 61 Zirgan 61 refractory Hodgkin lymphoma 61 SUMAVEL 61 Squalamine 61 2 methoxyestradiol 61 HuMax TAC 61 Pharmacokinetics PK 61 RSD# 61 rALLy 61 inhibitor RG# 61 platelet inhibitor 61 methylnaltrexone 61 PSN# [002] 61 Mylotarg 61 Glufast 61 IV acetaminophen 61 adecatumumab MT# 61 Fentanyl Taifun 61 gemcitabine carboplatin 61 TransVax TM 61 prokinetic agent 61 Æterna Zentaris 61 Zerenex 61 XL# XL# XL# 61 Trofex 61 Reolysin 61 Orapred ODT 61 HGS ETR2 61 CYT# vascular disrupting 61 SANVAR 61 Trofex TM 61 TransMID 61 DACH platinum 61 Mepact 61 AQ4N 61 haematologic 61 Clolar ® 61 Allovectin 7 R 61 bevacizumab Avastin 61 miRview mets 61 darinaparsin 61 liposome formulations 61 efficacy tolerability 61 intravenous immunoglobulin IVIG 61 Phase 1b trial 61 liprotamase 61 vascular disrupting agents 61 TheraCIM 61 humanized antibody 61 Excellagen 61 Interferon Alpha 61 vinca alkaloid 61 torezolid 61 product Fentanyl TAIFUN 61 NVA# 61 BAY #-# 61 TM Drug Eluting 61 CytoSorb TM 61 thetreatment 61 registrational 61 phase IIa 61 dose melphalan 61 Gefitinib 61 Omacetaxine 61 PEG PAL 61 LHRH antagonists 61 Surfaxin LS 61 Tumor Response 61 TEMODAL 61 PRX# 61 DUROS 61 anidulafungin 61 MedPulser 61 Transdel TM 61 Alinia 61 nonclinical studies 61 Sirolimus eluting Coronary Stent 61 albumin bound paclitaxel 61 DCCR 61 PEG SN# 61 anti emetic therapy 61 Folotyn 61 TAXUS Element Stent System 61 Canvaxin TM 61 Cetrorelix 61 Orathecin 61 convenient dosing regimens 61 2 inhibitor CYT# 61 GEM OS1 61 SPIRIVA HandiHaler 61 idarubicin 61 Drug Eluting Stent System 61 Lenocta 61 JAK3 inhibitor 61 PREOS R 61 orally inhaled 61 candidates Azedra TM 61 Spheramine 61 rBChE 61 metastatic HRPC 61 CORT # 61 Combination REOLYSIN R 61 Abiraterone acetate 61 RhuDex R 61 velafermin 61 investigational HCV polymerase 61 Intravenous CP 61 Guanilib 61 gastrointestinal disorders ATI 61 multicenter Phase 61 Zalypsis 61 dexanabinol 61 Cefepime 61 Kahalalide F 61 ONGLYZA ™ 61 bioabsorbable polymer 61 thorough QT 61 tafamidis 61 Pivotal Clinical Trial 61 dorzolamide 61 Vidaza R 61 APOPTONE